Somnarus Inc. is a medical diagnostic company whose innovative products address the significant unmet need of patients with obstructive sleep apnea. With 50 million Americans at risk for sleep apnea and the average medical insurance reimbursement rate of $160 per test, Somnarus is entering the market, whose potential is estimated at $8B. Only